NWAM LLC’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

NWAM LLC’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,800	Closed	-$7K	–	369
2018 Q2	$7K	Sell	18,800 -1,200	-6%	-$984	﹤0.01%	341
2018 Q1	$30K	Hold	20,000	–	–	0.01%	341
2017 Q4	$28K	Sell	20,000 -7,000	-26%	-$11.5K	0.01%	320
2017 Q3	$62K	Hold	27,000	–	–	0.02%	320
2017 Q2	$36K	Sell	27,000 -15,100	-36%	-$21.8K	0.01%	318
2017 Q1	$90K	Sell	42,100 -5,000	-11%	-$18.8K	0.03%	299
2016 Q4	$208K	Hold	47,100	–	–	0.07%	256
2016 Q3	$228K	Buy	+47,100	New	+$215K	0.02%	233

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

NWAM LLC's ARLZ Position: Q3 2018 in Review

NWAM LLC sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 18,800 shares — an estimated $7K sold.

NWAM LLC first reported a position in ARLZ in Q3 2016 and held it in 8 quarters. The position peaked at $228K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

NWAM LLC reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
NWAM LLC sold 18,800 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $7K.
NWAM LLC first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and held it in 8 quarters.
NWAM LLC's Aralez Pharmaceuticals Inc. position peaked at $228K in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on NWAM LLC's 13F filing for Q3 2018, filed 9 Oct 2018.